Company profile
Cyclacel Pharmaceuticals company profile
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a recognized leader in the field of tumor suppressor biology, who discovered the p53 protein, founded the Company in 1996. In 1999, Cyclacel Pharmaceuticals was joined by Professor David Glover, a recognized leader in the mechanism of mitosis or cell division, who discovered, among other cell cycle targets, the mitotic kinases, Polo and Aurora, enzymes that act in the mitosis phase of the cell cycle.
Business identity
- Website
- http://cyclacel.com
- Contact email
- [email protected]
- Phone number
- +1 (908) 517 7330
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0+
- Founded
- 1996-01-01, Year
Headquarters
- Headquarters
- Berkeley Heights, New Jersey, United States
- Postal code
- 07922
- Country code
- US
- Continent
- North America